317 related articles for article (PubMed ID: 38464516)
1. Cancer to bone: a fatal attraction.
Weilbaecher KN; Guise TA; McCauley LK
Nat Rev Cancer; 2011 Jun; 11(6):411-25. PubMed ID: 21593787
[TBL] [Abstract][Full Text] [Related]
2. Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors.
Chen S; Lei J; Mou H; Zhang W; Jin L; Lu S; Yinwang E; Xue Y; Shao Z; Chen T; Wang F; Zhao S; Chai X; Wang Z; Zhang J; Zhang Z; Ye Z; Li B
Front Immunol; 2024; 15():1335366. PubMed ID: 38464516
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
Futakuchi M; Fukamachi K; Suzui M
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
[TBL] [Abstract][Full Text] [Related]
4. Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth.
Kreps LM; Addison CL
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805598
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic Microenvironment and Metastatic Bone Disease.
Hiraga T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423905
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the role of bone marrow stromal cells on bone metastases.
Buenrostro D; Park SI; Sterling JA
Biomed Res Int; 2014; 2014():875305. PubMed ID: 25054153
[TBL] [Abstract][Full Text] [Related]
7. Myeloid regulatory cells in tumor spreading and metastasis.
Keskinov AA; Shurin MR
Immunobiology; 2015 Feb; 220(2):236-42. PubMed ID: 25178934
[TBL] [Abstract][Full Text] [Related]
8. Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms.
Joseph GJ; Johnson DB; Johnson RW
J Bone Oncol; 2023 Dec; 43():100505. PubMed ID: 37842554
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast-derived apoptotic bodies inhibit naive CD8
Wu Y; Ai H; Xi Y; Tan J; Qu Y; Xu J; Luo F; Dou C
Cell Rep Med; 2023 Sep; 4(9):101165. PubMed ID: 37607544
[TBL] [Abstract][Full Text] [Related]
10. SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches.
Wu Q; Tian P; He D; Jia Z; He Y; Luo W; Lv X; Wang Y; Zhang P; Liang Y; Zhao W; Qin J; Su P; Jiang YZ; Shao ZM; Yang Q; Hu G
Cell Res; 2023 Jun; 33(6):464-478. PubMed ID: 37142671
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis.
Ye X; Huang X; Fu X; Zhang X; Lin R; Zhang W; Zhang J; Lu Y
J Hematol Oncol; 2023 May; 16(1):46. PubMed ID: 37138326
[TBL] [Abstract][Full Text] [Related]
12. Metastatic prostate cancer-derived extracellular vesicles facilitate osteoclastogenesis by transferring the CDCP1 protein.
Urabe F; Kosaka N; Yamamoto Y; Ito K; Otsuka K; Soekmadji C; Egawa S; Kimura T; Ochiya T
J Extracell Vesicles; 2023 Mar; 12(3):e12312. PubMed ID: 36880252
[TBL] [Abstract][Full Text] [Related]
13. TFAM deficiency in dendritic cells leads to mitochondrial dysfunction and enhanced antitumor immunity through cGAS-STING pathway.
Lu T; Zhang Z; Bi Z; Lan T; Zeng H; Liu Y; Mo F; Yang J; Chen S; He X; Hong W; Zhang Z; Pi R; Ren W; Tian X; Wei Y; Luo M; Wei X
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36858460
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
